Unknown

Dataset Information

0

Targeting several CAG expansion diseases by a single antisense oligonucleotide.


ABSTRACT: To date there are 9 known diseases caused by an expanded polyglutamine repeat, with the most prevalent being Huntington's disease. Huntington's disease is a progressive autosomal dominant neurodegenerative disorder for which currently no therapy is available. It is caused by a CAG repeat expansion in the HTT gene, which results in an expansion of a glutamine stretch at the N-terminal end of the huntingtin protein. This polyglutamine expansion plays a central role in the disease and results in the accumulation of cytoplasmic and nuclear aggregates. Here, we make use of modified 2'-O-methyl phosphorothioate (CUG)n triplet-repeat antisense oligonucleotides to effectively reduce mutant huntingtin transcript and protein levels in patient-derived Huntington's disease fibroblasts and lymphoblasts. The most effective antisense oligonucleotide, (CUG)(7), also reduced mutant ataxin-1 and ataxin-3 mRNA levels in spinocerebellar ataxia 1 and 3, respectively, and atrophin-1 in dentatorubral-pallidoluysian atrophy patient derived fibroblasts. This antisense oligonucleotide is not only a promising therapeutic tool to reduce mutant huntingtin levels in Huntington's disease but our results in spinocerebellar ataxia and dentatorubral-pallidoluysian atrophy cells suggest that this could also be applicable to other polyglutamine expansion disorders as well.

SUBMITTER: Evers MM 

PROVIDER: S-EPMC3164722 | biostudies-literature | 2011

REPOSITORIES: biostudies-literature

altmetric image

Publications


To date there are 9 known diseases caused by an expanded polyglutamine repeat, with the most prevalent being Huntington's disease. Huntington's disease is a progressive autosomal dominant neurodegenerative disorder for which currently no therapy is available. It is caused by a CAG repeat expansion in the HTT gene, which results in an expansion of a glutamine stretch at the N-terminal end of the huntingtin protein. This polyglutamine expansion plays a central role in the disease and results in th  ...[more]

Similar Datasets

| S-EPMC6695277 | biostudies-literature
| S-EPMC7427431 | biostudies-literature
| S-EPMC3421186 | biostudies-literature
| S-EPMC9780395 | biostudies-literature
| S-EPMC8778715 | biostudies-literature
| S-EPMC129321 | biostudies-literature
| S-EPMC6419472 | biostudies-literature
| S-EPMC5801198 | biostudies-literature
| S-EPMC10570754 | biostudies-literature
| S-EPMC6777919 | biostudies-literature